About The Leukemia & Lymphoma Society®

The Leukemia & Lymphoma Society®


The mission of The Leukemia & Lymphoma Society® (LLS) is: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS, founded in 1949, is the world’s largest voluntary health agency dedicated to blood cancer. LLS funds lifesaving blood cancer around the world and provides free information and support services. LLS’s Key Priorities will ensure that: The Leukemia & Lymphoma Society® helps blood cancer patients live better, longer lives. Not Someday. Today.

Investing in blood cancer research: LLS has invested nearly $1 billion in research, approximately $68.4 million in fiscal year 2012 alone. Programs like the Specialized Center of Research (SCOR), which brings together teams of scientists from different disciplines and their Translational Research Program, which funds research with a high probability of producing innovative patient treatments in an accelerated time frame, have directly contributed  to many breakthrough cancer treatments. Research funded by LLS has led or contributed to advances such as chemotherapy, bone marrow and stem cell transplantation and new, targeted oral therapies, such as Gleevec®, Rituxan®, Velcade®, Thalidomid®, Revlimid®, Istodax®, Zolinza®, Dacogen®, and Vidaza®.

Providing critical information and support for patients and their families: LLS makes contact with patients, caregivers and healthcare professionals through their Information Resource Center (IRC), their award winning Web site and community-based patient service programs. LLS puts people together with experts through Web-casts and teleconferences, and provides professional education through seminars, to extend the latest finding to a broader professional audience.

Advocating for issues impacting blood cancer patients: With more than 66,000 advocacy volunteers throughout the country, LLS’s voice is being heard by those responsible for legislation to fund blood cancer research and educational programs.

The need is critical: An estimated 1,012,533 people in the United States are living with, or are in remission from, leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma or myeloma. Approximately every four minutes, someone new is diagnosed with a blood cancer. Approximately every 10 minutes, someone dies. Leukemia causes more deaths than any other cancer among children, adolescents and young adults under the age of 20 years old. Lymphomas are the most common blood cancers and incidence increases with age.

The Leukemia & Lymphoma Society® is a 501(c)(3) charitable organization. Financial information, including Form 990s on the organization can be found on Guidestar. The Leukemia & Lymphoma Society® is accredited with The Better Business Bureau, meeting all 20 standards for charitable accountability and is certified by HonCode, Health on the Net Foundation.

For more information about The Leukemia & Lymphoma Society®, please contact the Eastern Pennsylvania Chapter at (800) 482-2873 or visit their website at www.LLS.org/epa.